BridgeBio Pharma, Inc.
BBIONasdaqCIK 1743881HealthcareFiscal year ends Dec 31
Reports and events: 183 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-04-2916:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-20-126364 |
| 2020-04-2217:22 ET | DEF 14A | Proxy statementPeriod 2020-06-02 | 0001140361-20-009469 |
| 2020-03-2406:06 ET | 8-K | 8.01 Other events | 0001193125-20-083085 |
| 2020-03-1021:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-067542 |
| 2020-03-0606:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-063716 |
| 2020-03-0407:21 ET | 8-K | 8.01 Other events | 0001193125-20-060890 |
| 2020-03-0306:07 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-008260 |
| 2020-03-0208:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-058049 |
| 2020-02-1917:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-042081 |
| 2020-01-0716:17 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-20-003038 |
| 2019-12-2616:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-323511 |
| 2019-12-1706:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-315521 |
| 2019-11-1916:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-295582 |
| 2019-11-0806:06 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-041986 |
| 2019-10-1509:27 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-267356 |
| 2019-10-1117:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-266824 |
| 2019-09-1206:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-243348 |
| 2019-08-1406:07 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-031927 |
| 2019-08-0816:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-216833 |
| 2019-07-1017:06 ET | SC 13D | Ownership report, active investor | 0001140361-19-012746 |
| 2019-07-0921:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-190741 |
| 2019-07-0816:46 ET | SC 13D | Ownership report, active investor | 0000903423-19-000277 |
| 2019-07-0316:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-189260 |
| 2019-06-2621:09 ET | S-1/A | Registration statement, amended | 0001193125-19-181551 |
| 2019-06-2407:12 ET | S-1/A | Registration statement, amended | 0001193125-19-179321 |
| 2019-06-1706:09 ET | S-1/A | Registration statement, amended | 0001193125-19-174178 |
| 2019-06-1106:26 ET | S-1/A | Registration statement, amended | 0001193125-19-169677 |
| 2019-05-3019:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-159860 |
| 2019-05-2416:46 ET | S-1 | Registration statement | 0001193125-19-157100 |
| 2018-12-1317:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-18-347912 |
| 2018-12-1119:27 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-18-346386 |
| 2018-12-0720:50 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-18-344046 |
| 2018-08-0108:02 ET | SC 13D | Ownership report, active investor | 0001193125-18-233959 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:56 ET. Listed shows no prices and gives no investment advice.